Clinical significance of high-Km 5′-nucleotidase (cN-II) mRNA expression in high-risk myelodysplastic syndrome

Leukemia Research

Volumn 31, Issue 10, 2007, Pages 1343-1349

  Suzuki, Keijiro ^a   Sugawara, Takeshi ^a   Oyake, Tatsuo ^a   Uchiyama, Toshiyuki ^a   Aoki, Yusei ^a   Tsukushi, Yasuhiko ^a   Onodera, Shima ^a   Ito, Shigeki ^a   Murai, Kazunori ^a   Ishida, Yoji ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Cytarabine; Cytoplasmic high Km 5 nucleotidase; Deoxycytidine kinase; Drug resistance; Myelodysplastic syndrome; Real time PCR

Indexed keywords

5' NUCLEOTIDASE; CYTARABINE; DEOXYCYTIDINE KINASE; ETOPOSIDE; IDARUBICIN; MESSENGER RNA; MITOXANTRONE;

ADULT; AGED; ARTICLE; BONE MARROW CELL; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; GENE EXPRESSION; HUMAN; LOW DRUG DOSE; MONONUCLEAR CELL; MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

5'-NUCLEOTIDASE; ANTIMETABOLITES, ANTINEOPLASTIC; BONE MARROW CELLS; CYTARABINE; DEOXYCYTIDINE KINASE; HUMANS; KAPLAN-MEIERS ESTIMATE; LEUKOCYTES, MONONUCLEAR; MYELODYSPLASTIC SYNDROMES; PRECANCEROUS CONDITIONS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 34547697440     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2007.01.018     Document Type: Article

References (31)

1. Kurzrock R. Myelodysplastic syndrome overview. Semin Hematol 39 (2002) 18-25
2. Galmarini C.M., Mackey J.R., and Dumontet C. Nucleoside analogues: mechanisms of drug resistance and reversal strategies. Leukemia 15 (2001) 875-890
3. Kufe D.W., Weichselbaum R., Egan E.M., Dahlberg W., and Fram R.J. Lethal effects of 1-beta-d-arabinofuranosylcytosine incorporation into deoxyribonucleic acid during ultraviolet repair. Mol Pharmacol 25 (1984) 322-326
4. Rustum Y.M., and Raymakers R.A. 1-Beta-arabinofuranosylcytosine in therapy of leukemia: preclinical and clinical overview. Pharmacol Ther 56 (1992) 307-321
5. Plagemann P.G., Marz R., and Wohlhueter R.M. Transport and metabolism of deoxycytidine and 1-beta-d-arabinofuranosylcytosine into cultured Novikoff rat hepatoma cells, relationship to phosphorylation, and regulation of triphosphate synthesis. Cancer Res 38 (1978) 978-989
6. Amici A., Emanuelli M., Magni G., Raffaelli N., and Ruggieri S. Pyrimidine nucleotidases from human erythrocyte possess phosphotransferase activities specific for pyrimidine nucleotides. FEBS Lett 419 (1997) 263-267
7. Amici A., and Magni G. Human erythrocyte pyrimidine 5′-nucleotidase, PN-I. Arch Biochem Biophys 397 (2002) 184-190
8. Schirmer M., Stegmann A.P., Geisen F., and Konwalinka G. Lack of cross-resistance with gemcitabine and cytarabine in cladribine-resistant HL60 cells with elevated 5′-nucleotidase activity. Exp Hematol 26 (1998) 1223-1228
9. Dumontet C., Fabianowska-Majewska K., Mantincic D., Callet Bauchu E., Tigaud I., Gandhi V., Lepoivre M., Peters G.J., Rolland M.O., Wyczechowska D., Fang X., Gazzo S., Voorn D.A., Vanier-Viornery A., and MacKey J. Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562. Br J Haematol 106 (1999) 78-85
10. Galmarini C.M., Graham K., Thomas X., Calvo F., Rousselot P., El Jafaari A., Cros E., Mackey J.R., and Dumontet C. Expression of high Km 5′-nucleotidase in leukemic blasts is an independent prognostic factor in adults with acute myeloid leukemia. Blood 98 (2001) 1922-1926
11. Galmarini C.M., Thomas X., Calvo F., Rousselot P., Rabilloud M., El Jaffari A., Cros E., and Dumontet C. In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia. Br J Haematol 117 (2002) 860-868
12. Galmarini C.M., Thomas X., Graham K., El Jafaari A., Cros E., Jordheim L., Mackey J.R., and Dumontet C. Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine. Br J Haematol 122 (2003) 53-60
13. Greenberg P., Cox C., LeBeau M.M., Fenaux P., Morel P., Sanz G., Sanz M., Vallespi T., Hamblin T., Oscier D., Ohyashiki K., Toyama K., Aul C., Mufti G., and Bennett J. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89 (1997) 2079-2088
14. Kuriya S., Murai K., Miyairi Y., Utsugisawa T., Narigasawa Y., Ito T., Shimosegawa K., and Ishida Y. A combination chemotherapy with low doses of cytarabine and etoposide for high-risk myelodysplastic syndromes and their leukemic stage. A pilot study. Cancer 78 (1996) 422-426
15. Rampazzo C., Gazziola C., Ferraro P., Gallinaro L., Johansson M., Reichard P., and Bianchi V. Human high-Km 5′-nucleotidase effects of overexpression of the cloned cDNA in cultured human cells. Eur J Biochem 261 (1999) 689-697
16. Fernandez-Calotti P., Jordheim L.P., Giordano M., Dumontet C., and Galmarini C.M. Substrate cycles and drug resistance to 1-beta-d-arabinofuranosylcytosine (araC). Leuk Lymphoma 46 (2005) 335-346
17. Galmarini C.M., Jordheim L., and Dumontet C. Role of IMP-selective 5′-nucleotidase (cN-II) in hematological malignancies. Leuk Lymphoma 44 (2003) 1105-1111
18. Galmarini C.M., Cros E., Thomas X., Jordheim L., and Dumontet. The prognostic value of cN-II and cN-III enzymes in adult acute myeloid leukemia. Haematologica 90 (2005) 1699-1701
19. Mazzon C., Rampazzo C., Scaini M.C., Gallinaro L., Karlsson A., Meier C., Balzarini J., Reichard P., and Bianchi V. Cytosolic and mitochondrial deoxyribonucleotidases: activity with substrate analogs, inhibitors and implications for therapy. Biochem Pharmacol 66 (2003) 471-479
20. Chiba P., Tihan T., Szekeres T., Salamon J., Kraupp M., Eher R., Koller U., and Knapp W. Concordant changes of pyrimidine metabolism in blasts of two cases of acute myeloid leukemia after repeated treatment with ara-C in vivo. Leukemia 4 (1990) 761-765
21. Gazziola C., Ferraro P., Moras M., Reichard P., and Bianchi V. Cytosolic high K(m) 5′-nucleotidase and 5′(3′)-deoxyribonucleotidase in substrate cycles involved in nucleotide metabolism. J Biol Chem 276 (2001) 6185-6190
22. Itoh R., Echizen H., Higuchi M., Oka J., and Yamada K. A comparative study on tissue distribution and metabolic adaptation of IMP-GMP 5′-nucleotidase. Comp Biochem Physiol B 103 (1992) 153-159
23. Miller K.B., Kim K., Morrison F.S., Winter J.N., Bennett J.M., Neiman R.S., Head D.R., Cassileth P.A., and O'Connell M.J. The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: a phase-III intergroup study. Ann Hematol 65 (1992) 162-168
24. Ooi K., Ohkubo T., Higashigawa M., Kawasaki H., and Sakurai M. Increased deoxycytidine kinase activity by etoposide in L1210 murine leukemic cells. Biol Pharm Bull 19 (1996) 1382-1383
25. Spasokoukotskaja T., Sasvari-Szekely M., Keszler G., Albertioni F., Eriksson S., and Staub M. Treatment of normal and malignant cells with nucleoside analogues and etoposide enhances deoxycytidine kinase activity. Eur J Cancer 35 (1999) 1862-1867
26. Ooi K., Ohkubo T., Kuwabara H., Higashigawa M., Kawasaki H., Kakitoh H., Kagawa Y., Inagaki S., Sumida K., and Sakurai M. Enhanced incorporation of 1-beta-d-arabinofuranosylcytosine by pretreatment with etoposide. Cancer Invest 11 (1993) 388-392
27. Ives D.H., and Durham J.P. Deoxycytidine kinase. III. Kinetics and allosteric regulation of the calf thymus enzyme. J Biol Chem 245 (1970) 2285-2294
28. Szyfter K., Sasvari-Szekely M., Spasokukotskaja T., Antoni F., and Staub M. Pyrimidine salvage enzymes in human tonsil lymphocytes: II. Purification and properties of deoxycytidine kinase. Acta Biochim Biophys Acad Sci Hung 20 (1985) 173-182
29. Xie K.C., and Plunkett W. Deoxynucleotide pool depletion and sustained inhibition of ribonucleotide reductase and DNA synthesis after treatment of human lymphoblastoid cells with 2-chloro-9-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl) adenine. Cancer Res 56 (1996) 3030-3037
30. Gandhi V., and Plunkett W. Cell cycle-specific metabolism of arabinosyl nucleosides in K562 human leukemia cells. Cancer Chemother Pharmacol 31 (1992) 11-17
31. Ooi K., Ohkubo T., Kawasaki H., and Sakurai M. Etoposide-induced deoxyribonucleic acid (DNA) damage and its effects on nucleotide pools in murine leukemia L1210 cells. Yakugaku Zasshi 110 (1990) 673-677